Background: Despite hVISA infections being associated with vancomycin treatment failure, no previous study has been able to detect a mortality difference between heteroresistant vancomycin intermediate Staphylococcus aureus (hVISA) and vancomycin susceptible Staphylococcus aureus (VSSA) bloodstream infections (BSI)
The best screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureu...
Background. There are concerns about reduced efficacy of vancomycin in patients with Staphylococcus ...
We reported an association between elevated vancomycin MIC and 30-day mortality in patients with Sta...
BACKGROUND: Despite hVISA infections being associated with vancomycin treatment failure, no previous...
Background: Despite hVISA infections being associated with vancomycin treatment failure, no previous...
The prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) infections var...
The prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) infections var...
The prevalence of heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) is 1.3% in p...
1<p>Reference group composed of all principle diagnoses with similar 30 day mortality.</p>2<p>The ef...
Staphylococcus aureus (S. aureus) has proven to be a major pathogen with the emergence of methicilli...
Background. There are concerns about reduced efficacy of vancomycin in patients with Staphylococcus ...
A total of 559 methicillin-resistant Staphylococcus aureus isolates were investigated for heterogene...
We conducted a retrospective study of the clinical aspects of bacteremia caused by methicillin-resis...
Infective endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA IE) is associated wi...
We assessed all episodes of methicillin-resistant Staphy-lococcus aureus (MRSA) bacteremia at our ho...
The best screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureu...
Background. There are concerns about reduced efficacy of vancomycin in patients with Staphylococcus ...
We reported an association between elevated vancomycin MIC and 30-day mortality in patients with Sta...
BACKGROUND: Despite hVISA infections being associated with vancomycin treatment failure, no previous...
Background: Despite hVISA infections being associated with vancomycin treatment failure, no previous...
The prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) infections var...
The prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) infections var...
The prevalence of heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) is 1.3% in p...
1<p>Reference group composed of all principle diagnoses with similar 30 day mortality.</p>2<p>The ef...
Staphylococcus aureus (S. aureus) has proven to be a major pathogen with the emergence of methicilli...
Background. There are concerns about reduced efficacy of vancomycin in patients with Staphylococcus ...
A total of 559 methicillin-resistant Staphylococcus aureus isolates were investigated for heterogene...
We conducted a retrospective study of the clinical aspects of bacteremia caused by methicillin-resis...
Infective endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA IE) is associated wi...
We assessed all episodes of methicillin-resistant Staphy-lococcus aureus (MRSA) bacteremia at our ho...
The best screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureu...
Background. There are concerns about reduced efficacy of vancomycin in patients with Staphylococcus ...
We reported an association between elevated vancomycin MIC and 30-day mortality in patients with Sta...